SCHEMBL6556977

SCHEMBL6556977

CC(C)Oc1ccc(CN)cc1CN[C@H]1CCCN[C@H]1c1ccccc1

nearest known ligand 0.74

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 19/20 0.74
CYP2D6 P10635 3/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6557108 0.89 TACR1 (0.77) TACR1CYP2D6
SCHEMBL22272194 0.86 TACR1 (0.77) TACR1CYP2D6
SCHEMBL9295001 0.86 TACR1 (0.77) TACR1CYP2D6
SCHEMBL31401661 0.86 TACR1 (0.77) TACR1CYP2D6
SCHEMBL6554936 0.86 TACR1 (1.00) TACR1CYP2D6
SCHEMBL6554939 0.86 TACR1 (1.00) TACR1CYP2D6
SCHEMBL6554931 0.86 TACR1 (1.00) TACR1CYP2D6
SCHEMBL6556858 0.85 TACR1 (0.76) TACR1CYP2D6
SCHEMBL6555029 0.85 TACR1 (0.76) TACR1CYP2D6
Hydrochloric Acid SCHEMBL7480501 0.85 TACR1 (0.74) TACR1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0721778-B1 NK-1 receptor antagonists for the treatment of neuronal injury and stroke PFIZER (US) 2004-03-03 EP claimed
US-6194436-B1 THERAPY FOR LUNG CANCER PFIZER INC. 2001-02-27 US claimed
EP-0854720-B1 NK-1 RECEPTOR ANTAGONISTS FOR PREVENTION OF NEUROGENIC INFLAMMATION IN GENE THERAPY PFIZER (US) 1999-08-04 EP claimed
EP-0773026-A2 NK-1 receptor antagonists for the treatment of cancer PFIZER INC. (US) 1997-05-14 EP claimed
EP-0659409-A2 Substance 1 antagonists for the inhibition of angiogenesis PFIZER INC. (US) 1995-06-28 EP claimed